Comparison of Droplet Digital PCR and Metagenomic Next-Generation Sequencing Methods for the Detection of Human Herpesvirus 6B Infection Using Cell-Free DNA from Patients Receiving CAR-T and Hematopoietic Stem Cell Transplantation

References

• Schuster SJ, Tam CS, Borchmann P, et al. Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study. Lancet Oncol. 2021;22(10):1403–1415. doi:10.1016/S1470-2045(21)00375-2
   PubMed Web of Science ®Google Scholar
• Locke FL, Ghobadi A, Jacobson CA, et al. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial. Lancet Oncol. 2019;20(1):31–42. doi:10.1016/S1470-2045(18)30864-7
   PubMed Web of Science ®Google Scholar
• Sauter CS, Senechal B, Rivière I, et al. CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma. Blood. 2019;134(7):626–635. doi:10.1182/blood.2018883421
   PubMed Web of Science ®Google Scholar
• Ueda MY, Alvarenga PG, Real JM, et al. Optimisation of a quantitative polymerase chain reaction-based strategy for the detection and quantification of human herpesvirus 6 DNA in patients undergoing allogeneic haematopoietic stem cell transplantation. Mem Inst Oswaldo Cruz. 2015;110(4):461–467. doi:10.1590/0074-02760150004
   Web of Science ®Google Scholar
• Handley G, Khawaja F, Kondapi DS, et al. Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy. Int J Infect Dis. 2021;112:327–329. doi:10.1016/j.ijid.2021.09.061
   Web of Science ®Google Scholar
• Zerr DM, Fann JR, Breiger D, et al. HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. Blood. 2011;117(19):5243–5249. doi:10.1182/blood-2010-10-316083
   Web of Science ®Google Scholar
• Ogata M, Oshima K, Ikebe T, et al. Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2017;52(11):1563–1570. doi:10.1038/bmt.2017.175
   Web of Science ®Google Scholar
• Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science. 1986;234(4776):596–601. doi:10.1126/science.2876520
   PubMed Web of Science ®Google Scholar
• Agut H, Bonnafous P, Gautheret-Dejean A. Laboratory and clinical aspects of human herpesvirus 6 infections. Clin Microbiol Rev. 2015;28(2):313–335. doi:10.1128/CMR.00122-14
   PubMed Web of Science ®Google Scholar
• Rebechi MT, Bork JT, Riedel DJ. HHV-6 encephalitis after chimeric antigen receptor T-cell therapy (CAR-T): 2 case reports and a brief review of the literature. Open Forum Infect Dis. 2021;8(11):ofab470. doi:10.1093/ofid/ofab470
   Web of Science ®Google Scholar
• Mori Y, Miyamoto T, Nagafuji K, et al. High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation. J Am Soc Blood Marrow Transplant. 2010;16(11):1596–1602.
   Web of Science ®Google Scholar
• Hill JA, Koo S, Guzman Suarez BB, et al. Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. J Am Soc Blood Marrow Transplant. 2012;18(11):1638–1648.
   Web of Science ®Google Scholar
• Beyar-Katz O, Kikozashvili N, Bar OY, et al. Characteristics and recognition of early infections in patients treated with commercial anti-CD19 CAR-T cells. Eur J Haematol. 2022;108(1):52–60. doi:10.1111/ejh.13712
   PubMed Web of Science ®Google Scholar
• Morris EC, Neelapu SS, Giavridis T, Sadelain M. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy. Nat Rev Immunol. 2022;22(2):85–96. doi:10.1038/s41577-021-00547-6
   PubMed Web of Science ®Google Scholar
• Neelapu SS, Tummala S, Kebriaei P, et al. Chimeric antigen receptor T-cell therapy - assessment and management of toxicities. Nat Rev Clin Oncol. 2018;15(1):47–62. doi:10.1038/nrclinonc.2017.148
   PubMed Web of Science ®Google Scholar
• Shimabukuro-Vornhagen A, Böll B, Schellongowski P, et al. Critical care management of chimeric antigen receptor T-cell therapy recipients. CA. 2022;72(1):78–93. doi:10.3322/caac.21702
   Web of Science ®Google Scholar
• Gutiérrez-Aguirre I, Rački N, Dreo T, Ravnikar M. Droplet digital PCR for absolute quantification of pathogens. Methods Mol Biol. 2015;1302:331–347.
   PubMedGoogle Scholar
• Chen B, Jiang Y, Cao X, Liu C, Zhang N, Shi D. Droplet digital PCR as an emerging tool in detecting pathogens nucleic acids in infectious diseases. Int J Clinical Chem. 2021;517:156–161. doi:10.1016/j.cca.2021.02.008
   Web of Science ®Google Scholar
• Zeng YF, Chen CM, Li XY, et al. Development of a droplet digital PCR method for detection of Streptococcus agalactiae. BMC Microbiol. 2020;20(1):179. doi:10.1186/s12866-020-01857-w
   Web of Science ®Google Scholar
• Di Meo A, Bartlett J, Cheng Y, Pasic MD, Yousef GM. Liquid biopsy: a step forward towards precision medicine in urologic malignancies. Mol Cancer. 2017;16(1):80. doi:10.1186/s12943-017-0644-5
   PubMed Web of Science ®Google Scholar
• Della Starza I, Nunes V, Cavalli M, et al. Comparative analysis between RQ-PCR and digital-droplet-PCR of immunoglobulin/T-cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia. Br J Haematol. 2016;174(4):541–549. doi:10.1111/bjh.14082
   PubMed Web of Science ®Google Scholar
• Wang D, Wang S, Du X, et al. ddPCR surpasses classical qPCR technology in quantitating bacteria and fungi in the environment. Mol Ecol Resour. 2022. doi:10.1111/1755-0998.13644
   Web of Science ®Google Scholar
• Gu W, Miller S, Chiu CY. Clinical metagenomic next-generation sequencing for pathogen detection. Annu Rev Pathol. 2019;14:319–338. doi:10.1146/annurev-pathmechdis-012418-012751
   PubMed Web of Science ®Google Scholar
• Long Y, Zhang Y, Gong Y, et al. Diagnosis of sepsis with cell-free DNA by next-generation sequencing technology in ICU patients. Arch Med Res. 2016;47(5):365–371. doi:10.1016/j.arcmed.2016.08.004
   PubMed Web of Science ®Google Scholar
• Dai Y, Chen L, Chang W, Lu H, Cui P, Ma X. Culture-negative streptococcus suis infection diagnosed by metagenomic next-generation sequencing. Public Health Front. 2019;7:379. doi:10.3389/fpubh.2019.00379
   Google Scholar
• Hiemcke-Jiwa LS, Minnema MC, Radersma-van Loon JH, et al. The use of droplet digital PCR in liquid biopsies: a highly sensitive technique for MYD88 p. (L265P) detection in cerebrospinal fluid. Hematol Oncol. 2018;36(2):429–435. doi:10.1002/hon.2489
   PubMed Web of Science ®Google Scholar
• Jeon YJ, Zhou Y, Li Y, et al. The feasibility study of non-invasive fetal trisomy 18 and 21 detection with semiconductor sequencing platform. PLoS One. 2014;9(10):e110240. doi:10.1371/journal.pone.0110240
   PubMed Web of Science ®Google Scholar
• Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754–1760. doi:10.1093/bioinformatics/btp324
   PubMed Web of Science ®Google Scholar
• Miao Q, Ma Y, Wang Q, et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice. Clin Infect Dis. 2018;67(suppl_2):S231–s240. doi:10.1093/cid/ciy693
   PubMed Web of Science ®Google Scholar
• Cordeiro A, Bezerra ED, Hirayama AV, et al. Late events after treatment with CD19-targeted chimeric antigen receptor modified T cells. J Am Soc Blood Marrow Transplant. 2020;26(1):26–33.
   PubMed Web of Science ®Google Scholar
• Nie J, Yang L, Huang L, et al. Infection complications in febrile chimeric antigen receptor (CAR)-T recipients during the peri-CAR-T cell treatment period examined using metagenomic next-generation sequencing (mNGS). Cancer Commun. 2022;42(5):476–480. doi:10.1002/cac2.12260
   Web of Science ®Google Scholar
• Shah M, Kuhnl A, Shields G, et al. Human herpesvirus 6 encephalitis following axicabtagene ciloleucel treatment for refractory diffuse large B cell lymphoma. HemaSphere. 2021;5(3):e535. doi:10.1097/HS9.0000000000000535
   Web of Science ®Google Scholar
• Handley G, Hasbun R, Okhuysen P. Human herpesvirus 6 and central nervous system disease in oncology patients: a retrospective case series and literature review. J Clin Virol. 2021;136:104740. doi:10.1016/j.jcv.2021.104740
   Web of Science ®Google Scholar
• Muta T, Fukuda T, Harada M. Human herpesvirus-6 encephalitis in hematopoietic SCT recipients in Japan: a retrospective multicenter study. Bone Marrow Transplant. 2009;43(7):583–585. doi:10.1038/bmt.2008.359
   Web of Science ®Google Scholar
• Zerr DM. Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. J Clin Virol. 2006;37(Suppl 1):S52–56. doi:10.1016/S1386-6532(06)70012-9
   Web of Science ®Google Scholar
• Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis. 2005;40(7):932–940. doi:10.1086/428060
   PubMed Web of Science ®Google Scholar
• Dulery R, Salleron J, Dewilde A, et al. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study. J Am Soc Blood Marrow Transplant. 2012;18(7):1080–1089.
   PubMed Web of Science ®Google Scholar
• Pritchett JC, Naesens L, Montoya JG. Treating HHV-6 infections: the laboratory efficacy and clinical use of anti-HHV-6 agents; 2014.
   Google Scholar
• Prichard MN, Whitley RJ. The development of new therapies for human herpesvirus 6. Curr Opin Virol. 2014;9:148–153. doi:10.1016/j.coviro.2014.09.019
   Web of Science ®Google Scholar
• Postel M, Roosen A, Laurent-Puig P, Taly V, Wang-Renault SF. Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective. Expert Rev Mol Diagn. 2018;18(1):7–17. doi:10.1080/14737159.2018.1400384
   PubMed Web of Science ®Google Scholar
• Bettegowda C, Sausen M, Leary RJ, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6(224):224ra224. doi:10.1126/scitranslmed.3007094
   Web of Science ®Google Scholar
• Garlan F, Laurent-Puig P, Sefrioui D, et al. Early evaluation of circulating tumor DNA as marker of therapeutic efficacy in metastatic colorectal cancer patients (PLACOL study). Clin Cancer Res. 2017;23(18):5416–5425. doi:10.1158/1078-0432.CCR-16-3155
   PubMed Web of Science ®Google Scholar
• Pécuchet N, Rozenholc Y, Zonta E, et al. Analysis of base-position error rate of next-generation sequencing to detect tumor mutations in circulating DNA. Clin Chem. 2016;62(11):1492–1503. doi:10.1373/clinchem.2016.258236
   PubMed Web of Science ®Google Scholar
• Beaver JA, Jelovac D, Balukrishna S, et al. Detection of cancer DNA in plasma of patients with early-stage breast cancer. Clin Cancer Res. 2014;20(10):2643–2650. doi:10.1158/1078-0432.CCR-13-2933
   PubMed Web of Science ®Google Scholar
• Lu XJD, Liu KYP, Zhu YS, Cui C, Poh CF. Using ddPCR to assess the DNA yield of FFPE samples. Biomol Detect Quantif. 2018;16:5–11. doi:10.1016/j.bdq.2018.10.001
   Google Scholar